Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Clinical trial NCT05269290 · COMPLETED

Trial details

NCT number: NCT05269290
Sponsor: Valenta Pharm JSC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human Acute Respiratory Infection Common Cold

Start date: 2021-09-23
Primary completion: 2022-04-29
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.